F2RL1 and diabetic kidney disease: PAR-1 and PAR-2 expressions were reported to be increased in diabetic kidneys, and dual blockade of PAR-1 and PAR-2 has been shown to improve diabetic nephropathy in type 1 diabetic Akita mice heterozygous for the endothelial nitric oxide synthase gene [48].